Clinical Study Reporting – Effects of the Coronavirus Pandemic
Webinar - Free Q&A Session
Description
| Event | Webinar |
| Type | Virtual Event |
| Language | English |
| Date(s) | 15 Jun. 2020 |
| Time | 17:00 - 18:00 |
| Duration | 1 hour |
Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.
Programme
| 17:00 |
Introduction to the Webinar Moderator(s): Mark Poulton, Poulton Quality Solutions |
|
Regulatory Guidelines laid down for CSRs
Louise Mawer, Mirabilitas
Seif Eddine Amara Madi, GSK
|
|
|
Statistical Aspects of Reporting and Data Integrity Issues
Nancy Carpenter, Veramed
|
|
|
Q&A and Discussion
Beat Widler, WS QMS
Cathy Dove, Dove Quality Solutions
Claire Khalil, Evlo Biosciences
Heather Sampson, University of Toronto
Hugh Davies, Oxford A Research Ethics Committee
Matt Jones, Digital Quality Associates
Michelle Gabriel, University College London
Sarah Hall, Mipsol Limited
Sylvia Kranich, SK Consulting
|
|
| 18:00 |
End of the Webinar |